Skip to Content

Joann L Ater

Present Title & Affiliation

Primary Appointment

Professor, Department of Pediatrics Patient Care, Division of Pediatrics, The University of Texas, MD Anderson Cancer Center, Houston, TX

Education & Training

Degree-Granting Education

1977 Washington University School of Medicine, St. Louis, MO, MD, Medicine
1973 Washington University, St. Louis, MO, AB, Biology

Postgraduate Training

1980-6/1983 Clinical Fellowship, Pediatric Hematology-Oncology, University of Utah, Salt Lake City, UT
1978-6/1980 Clinical Residency, Pediatrics, University of Utah, Salt Lake City, UT
1977-6/1978 Clinical Internship, Pediatrics, Case Western Reserve University, Rainbow Babies and Children's Hospital, Cleveland, OH

Board Certifications

10/1982 Pediatric Hematology-Oncology
2/1982 American Board of Pediatrics


Other Appointments/Responsibilities

Member, Pediatric Operations Management Committee, 1/2001-present
Member, Central Nervous System Tumor Disease Committee of Children' Oncology Group (COG), 1/2001-present
Member, Voting Administrative Body for COG, 2001-2011
Committee Chair, Study Committee, CCG-B951: "Prognostic significance of Ki-67 proliferative index utilizing the MIB-I antibody in low grade gliomas in children", 1996-2006
Chairman, Study Committee A-9952 (COG) "Treatment with chemotherapy of children less than 10 years of age with progressive low-grade astrocytoma", 1995-present

Institutional Committee Activities

Member, PRS Retirement Board, 9/2010-present
Elected member, MDACC Faculty Senate, 8/2010-8/2012
member, Medical Practice Committee, 9/2009-present
Member, Survivorship textbook Committee, 8/2009-present
Member, Survivorship Conference Committee, 3/2009-present
Member, Survivorship Education Committee, 9/2008-present
Chair, Childhood Cancer Survivor Program Committee, 11/2006-present
Member, Clinical Survivorship Research Workgroup, 9/2006-2012
Member, Clinical Faculty Review Committee (CFRC), 9/2006-8/2009
Member, Survivorship Research Task Force, 2006-2012

Selected Publications

Peer-Reviewed Original Research Articles

1. Badr H, Chandra J, Paxton RJ, Ater JL, Urbauer D, Cruz CS, Demark-Wahnefried W. Health Related Quality of Life, Lifestyle, Behaviors, and Intervention Preferences of Survivors of Childhood Cancer,. J Cancer Surviv 7(4):523-534, 12/2013. e-Pub 6/2013. PMCID: PMC3825822.
2. Beltran A, Li R, Ater J, Baranowski J, Buday R, Thompson D, Chandra J, Baranowski T. Adapting a Video Game to the Needs of Pediatric Cancer Patients and Survivors. Games for Health Journal 2(4), 7/2013.
3. Ater JL. Procarbazine and Infertility in Low-Grade Gliomas in Children, letter to editor in reply to Toledano et. al. Journal of Clinical Oncology 30(36):4583-4, 12/2012.
4. Paxton RJ, Jones LW, Rosoff PM, Bonner M, Ater JL, Demark-Wahnefried W. Association between leisure-time physical activity and health-related quality of life among adolescent and adult survivors of childhood cancers. Psycho-Oncology 19(9):997-1003, 9/2010. PMCID: PMC2888632.
5. Kumar AJ, Leeds NE, Kumar VA, Fuller GN, Lang FF, Milas Z, Weinberg JS,Ater JL, Sawaya R. Magnetic resonance imaging features of pilocytic astrocytoma of the brain mimicking high grade gliomas. J Comput Assist Tomogr 34(4):601-11, 7/2010. PMID: 20657231.


1. Sadighi ZS, Ellezam B, Guindani M, Ater J. MDACC Experience with clinical and molecular heterogeneity in pediatric pilocytic astrocytoma. oral presentation at the Fourth Quadrennial Meeting of the World Federation of Neuro-Oncology, hosted by the Society for Neuro-Oncology, November 21-24, 2013, 11/2013.
2. Ater JA, Kim S, Yarbrough a, Badeaux C. Cardiovascular Health Status of Childhood Cancer Survivors. Presented at the 13th International Conference on Long-Term Complications of Treatment of Children and Adolescents for Cancer, Memphis, TN, June 13-15, 2013, 6/2013.
3. Ater J, Zhou T, Holmes E, Booth T, Freyer D, Packer R, et al. Carboplatin and vincristine as treatment for progressive hypothalamic/ optic pathway gliomas in children with neurofibromatosis type 1 (NF!) and risk of second malignant neoplasms: A report from the Children’s Oncology Group (COG). Pediatric Blood & Cancer 59(6):1077-78 (#ABST PM017), 12/2012.
4. Yarbrough A, Kim S, Badeaux C, Xu A, Ater JL. Lipid profile abnormality in childhood cancer survivors; a potential treatable target for prevention of cardiovascular disease. Presented at 12th International Conference on Long-Term Complications of Treatment of Children and Adolescents for Cancer, Williamsburg, VA, 2012, 2012.
5. Robert R, Palla S, Yang G, Askins M, Joy S, Ater JL. Quality of Life as A Population Health Outcome Evaluation. The 43rd Congress of The International Society for Pediatric Oncology 57(5):745, 2011.
6. Ater JL, Cruz CS, Xu AH, Faith Okcu M, Bondy M. Factors Influencing Adherence to Follow-Up Care in Childhood Cancer Survivors. Pediatric Blood and Cancer 55(5):942, 11/2010.
7. Ater JL, Paxton R, Bispeck K, Xu A, Cruz CS, Askins M, Urbauer D, Basen-Enquist K, Demark-Wahnefried W. Health Behaviors and Preferences of Childhood Cancer Survivors. Pediatric Blood and Cancer 55(5):942, 11/2010.
8. Ater JL, Xu A, Cruz CS, Mahajan A, Weinberg JS. Long Term Follow-Up of Children Treated for Low Grade Glioma. Neuro-Oncology 12(6):ii98, 6/2010.
9. Robert R, Askins M, Palla S, Yang G, Ater JL. Quality of Life Survivors of Childhood Cancer: A Life Span Development Perspective. Pediatric Blood and Cancer 55(5):1009, 2010.

Book Chapters

1. Ater, JL. Glioma. In: Evidence-Based Pediatric Oncology, 3. Ed(s) R Pinkerton, A Shankar, K Matthay. Wiley-Blackwell Publishing: New Jersey, 2013.

Grant & Contract Support

Title: Childhood Cancer Survivor Program
Funding Source: Astros in Action Foundation
Role: Principal Investigator
Duration: 7/1/2006 - 2012
Title: Children's Oncology Group Chairs' Grant
Funding Source: NIH/NCI
Role: Principal Investigator
Duration: 1/1/2003 - 12/31/2008

Last updated: 7/24/2015